Valeant Pharmaceuticals reported $-69000000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Amgen AMGN:US $ 1476M 423M
Ani Pharmaceuticals ANIP:US $ -20.13M 4.01M
Aurora Cannabis Inc ACB:CN -1012177000 937.4M
Biogen BIIB:US $ 303.8M 64.4M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Canopy Growth Corp WEED:CN C$ -574616000 465.69M
Catalent CTLT:US $ 141M 44M
Corcept Therapeutics CORT:US $ 22.8M 9.26M
Danaher DHR:US $ 1725M 63M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Endo International Ordinary Shares ENDP:US $ -71.97M 490.09M
Gilead Sciences GILD:US $ 19M 363M
Horizon Pharma HZNP:US $ 204.26M 31.08M
Lannett LCI:US $ -34.9M 46.19M
Nektar Therapeutics NKTR:US $ -145.65M 15.94M
Pacira Pharmaceuticals PCRX:US $ 6.83M 11.96M
Perrigo Ordinary Shares PRGO:US $ -2.4M 12M
Phibro Animal Health PAHC:US $ 17.69M 0.22M
Prestige Brands PBH:US $ 52.09M 1.87M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Supernus Pharmaceuticals SUPN:US $ 25.62M 23.17M
Valeant Pharmaceuticals VRX:CN $ -69M 138M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Zoetis ZTS:US $ 595M 181M